Brillia Health Cold-Flu Recovery
- Product NDC
- 72123-006
- 11-digit product format
- 721230006
- Labeler code
- 72123
- Product ID
- 72123-006_d5e20d53-a765-5fb4-e053-2995a90a08c5
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Lapine Histamine Immune Globulin (12C, 30C, 50C), Lapine Interferon Gamma Immune Globulin (12C, 30C, 50C), Lapine CD4 Immune Globulin (12C, 30C, 50C)
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Hadaf LLC
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2020-07-31
- Marketing end
- 0000-00-00
- Substance
- LAPINE CD4 IMMUNE GLOBULIN; LAPINE HISTAMINE IMMUNE GLOBULIN; LAPINE INTERFERON GAMMA IMMUNE GLOBULIN
- Active strength
- 12 [hp_C]/1; [hp_C]/1; [hp_C]/1
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 72123-006 | D | Discontinued by firm | 2026-10-12 | ||
| excluded package | package | 72123-006 | 72123-006-01 | D | Discontinued by firm | 2026-10-12 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 72123-006-01 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 72123-006-01 | f5e01cc5f278… | a2eaf40c39c3… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 72123-006-01 | 72123000601 | 2 BLISTER PACK in 1 BOX (72123-006-01) > 20 TABLET in 1 BLISTER PACK | 2 blister pack | 2020-07-31 | 0000-00-00 | No | No | Current |